Hand, foot and mouth disease
Therapeutic area
Dermatology
Rare disease
No
- Definition
- A clinical syndrome that is usually caused by enterovirus infection, and that is characterized by fever, anorexia, and painful sores in the mouth, distal extremities, and/or other sites, including the buttocks.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Hand, foot and mouth disease
- Therapeutic area
- Dermatology
- hand, foot and mouth disease
- HFMD
- hand foot and mouth disease
- hand, foot, and mouth disease
- Disease mechanisms
- Acquired
- Severity
- Mild
- Dermatology
- Infectious Disease
- MONDO ID
- MONDO:0005779
- Parent condition
- MONDO:0005721
Related records
Broader conditions (14)
- Coxsackievirus infectious disease
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Enterovirus infectious disease
- Human disease
- Infectious disease
- Integumentary system disorder
- Picornaviridae infectious disease
- Primary viral infectious disease
- Skin disorder
- Skin disorder caused by infection
- Viral infectious disease
Trials (60)
- A Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants
- A Clinical Trial for Inactivated Vaccine(Vero Cell) Against EV71 in Chinese Healthy Young Adults and Children
- A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 Months
- A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
- A Clinical Trial to Evaluate the Effectiveness and Safety of Chinese Medicine in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
- A Clinical Trial to Evaluate the Effectiveness and Safety of Xiyanping Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
- A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine
- A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease
- A Phase II, Safety and Efficacy Study of Inactivated EV 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants
- A Protected Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants and Children
- A Safety Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Adults, Children and Infants
- A Serosurvey Study of Hand, Foot, and Mouth Disease in Indonesia
- A Study to Evaluate the Efficacy, Immunogenicity and Safety of an EV71 Vaccine in Healthy Infants and Children
- A Study to Evaluate the Immunogenicity and Safety of EV71 Vaccine in Pediatric Subjects
- A Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine in Pediatric Subjects Aged 3 to 6 Years and 6 to 35 Months Old
- Active Case Finding of Clinical Hand Foot Mouth Disease in Children Aged 6 Months Old to 18 Years Old in Indonesia
- An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine
- An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)
- Artificial Intelligence-driven Virtual Standardized Pediatric Patients Trial
- Bridging Clinical Trial of EV71 Vaccine in Vietnamese Children
Drugs in development (2)
- Magnesium sulfate Phase 2
- Suramin hexasodium Phase 1